Viable Circulating Tumor Cells from Patient Blood: A Chip-free Approach for Clinical Labs is the first of 12 programs in AACC’s “Cutting-Edge Technologies, Common-Sense Solutions” webinar series. Although there are still technological challenges to overcome in isolating, characterizing and measuring circulating tumor cells (CTCs), the ability to use CTCs as tumor biomarkers could change the future of cancer detection and treatment. Attend this webinar to find out what’s happening in this important area of research and what role labs could potentially play in the measurement and interpretation of CTCs.